Patient Support Services Contact Us
Image: Coherus Investors

Snapshot

Revenue & Earnings

Revenue (FY) $475.82
EBIT (Mil) (FY) $156.32
EBIT (Mil) (MRQ) $16.43
EBIT (Mil) (TTM) $156.32
EBITDA (Mil) (FY) $159.21
EBITDA (Mil) (MRQ) $17.27
EBITDA (Mil) (TTM) $159.21
Net Income Excluding Extraordinary Items (Mil) (FY) $132.24
Net Income Including Extraordinary Items (Mil) (FY) $132.24
Diluted EPS Excluding Extraordinary Items (FY) $1.62
Diluted EPS Including Extraordinary Items (FY) $1.62

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --%

Ratios

Price to Revenue (TTM) $2.25
Price to Revenue (MRQ) $2.41
Price to Revenue (FY) $2.25
Price To Cash Flow (TTM) $7.91
Price to Cash Flow (MRQ) $25.28
Price to Cash Flow (FY) $7.92
Price to Book (MRQ) $3.78
Price to Book (FY) $3.78
Total Debt to Equity (MRQ) (%) 144.30%
Total Debt to Equity (FY) (%) 144.30%
Current Ratio (MRQ) $5.27
Current Ratio (FY) $5.27

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) 73.76%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Refinitiv